CHA ÀÇ°úÇдëÇб³ Â÷º´¿ø professor

±³¼ö´Ô»çÁø
  • ±èÀ¯½Å
  • ¼Ò ¼Ó: Â÷¿©¼ºÀÇÇבּ¸¼Ò ¼­¿ï¿ª¼¾ÅÍ
  • Àü¹®ºÐ¾ß : ½ÃÇè°ü, ¹Ì¼º¼÷ ½ÃÇè°ü, ¹Ýº¹½ÇÆÐ ¹× Àú¹ÝÀÀ±º ½ÃÇè°ü, PGT, ´ÙºóÄ¡ ·Îº¿ ¹× ¹Ì¼¼ º¹°­°æ ¼ö¼ú
  • Á÷ À§: ±³¼ö
  • ¸Þ ÀÏ: .
  • Àü È­: 02-2002-0300
  • ÆÑ ½º:
  • ÁÖ ¼Ò: ¼­¿ï½Ã Áß±¸ ÇÑ°­´ë·Î 416 ¼­¿ï½ºÄù¾î 2Ãþ Â÷º´¿ø ¿©¼ºÀÇÇבּ¸¼Ò ¼­¿ï¿ª¼¾ÅÍ
  • ȨÆäÀÌÁö:
  • ·Î±×ÀÎ

ÅǸ޴º

ÁÖ¿ä¹ßÇ¥³í¹®

µî·Ï

ÁÖ¿ä¹ßÇ¥³í¹®
¹øÈ£ ±¸ºÐ Á¦¸ñ ´Ù¿î·Îµå
20 ÇØ¿Ü Predictive value of antral follicle count and serum anti-Mullerian hormone: Which is better for live birth prediction in patients aged over 40 with their first IVF treatment? Eur J Obstet Gynecol Reprod Biol. vol21( 151-155)2017.12.26.  
19 ÇØ¿Ü Increased proportion of mature oocytes with sustained-release growth hormone treatment in poor responders: a prospective randomized controlled study. Arch Gynecol Obstet.Vol 29. 791-796.2017.9.19  
18 ÇØ¿Ü Therapeutic outcomes of methotrexate injection in unruptured interstitial pregnancy.Obstetrics & gynecology science. vol 60.No6.571-578.2017.6.20  
17 ÇØ¿Ü Chronic endometritis and infertility.Clin Exp Reprod Med. vol43.No4.185-192 2016.6.30.  
16 ÇØ¿Ü Successful management of heterotopic cornual pregnancy with laparoscopic cornual resection.Eur J Obstet Gynecol Reprod Biol.2016.8.15.Vol 203 199-203  
15 ÇØ¿Ü Application of serum anti-M?lerian hormone levels in selecting patients with polycystic ovary syndrome for in vitro maturation treatment.Clin Exp Reprod Med. 2016.6.1. vol43,No2 126-132  
14 ÇØ¿Ü Association between sex steroids, ovarian reserve, and vitamin d levels in healthy nonobese women.J Clin Endocrinol Metab.2014.7.1.vol99.No7 .2526-2532  
13 ÇØ¿Ü Impact on ovarian reserve after laparoscopic ovarian cystectomy with reduced port number: a randomized controlled trial.Eur J Obstet Gynecol Reprod Biol.10.1016/j.ejogrb.2014.02.025.2014.2.9.  
12 ÇØ¿Ü Molecular genetic and cytogenetic characterization of a partial Xp duplication and Xq deletion in a patient with premature ovarian failure.Gene.2013.6.8.Vol534.No1.54-59  
11 ÇØ¿Ü Combined medroxyprogesterone acetate (MPA)/Levonorgestrel-intrauterine system (LNG-IUS) treatment in young women with early-stage endometrial cancer.Am J Obstet Gynecol.2013.6.17.Vol209,No4.358  
ÀÌÀüÆäÀÌÁö À̵¿ 1 2 3 ´ÙÀ½ÆäÀÌÁö À̵¿
Copyright ¨Ï chamc, All rights reserved.

ºü¸£°í Æí¸®ÇÑ ÀÎÅÍ³Ý Áø·á¿¹¾à

  • °­³²Â÷º´¿ø
  • ºÐ´çÂ÷º´¿ø
  • ºÐ´çÂ÷¿©¼ºº´¿ø
  • ±¸¹ÌÂ÷º´¿ø
  • ¿©¼ºÀÇÇבּ¸¼Ò
  • Â÷¿ò

ÀüÈ­¹®ÀÇ

  • °­³²Â÷º´¿ø 02.3468.3000
  • ºÐ´çÂ÷º´¿ø 031.780.5000
  • Â÷¿ò 02.3015.5300
  • ±¸¹ÌÂ÷º´¿ø 054.450.9700
  • ´ë±¸¿©¼ºÂ÷º´¿ø 02.222.4200
  • °­³²°ÇÁø¼¾ÅÍ 02.2191.3900
  • ºÐ´çÁ¾ÇÕ°Ç°­ÁõÁø¼¾ÅÍ 031.780.5940
  • ½ºÆ÷·º½º °ÇÁø¼¾ÅÍ 02.3473.2111
  • ±¸¹ÌÂ÷º´¿ø°ÇÁø¼¾ÅÍ 054.450.9800
  • ȨÆäÀÌÁö°ü¸®ÀÚ 031.780.1729